Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Aurum Biosciences, a UK-based acute ischaemic stroke treatment spinout of University of Glasgow and public health board NHS Greater Glasgow and Clyde, has received around £670,000 ($875,000) in equity funding from investors including Scottish Health Innovations, the commercialisation arm of national healthcare provider NHS Scotland, Pharmiweb reported on Monday.  The round also featured vertically-integrated drug…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.